Related references
Note: Only part of the references are listed.Evaluation of a Newly Developed Lateral Flow Immunoassay for the Diagnosis of Cryptococcosis
Mark D. Lindsley et al.
CLINICAL INFECTIOUS DISEASES (2011)
Testing but not treating: missed opportunities and lost lives in the South African antiretroviral therapy programme
Joseph N. Jarvis et al.
AIDS (2010)
Cost-Effectiveness of Serum Cryptococcal Antigen Screening to Prevent Deaths among HIV-Infected Persons with a CD4+ Cell Count ≤100 Cells/mL Who Start HIV Therapy in Resource-Limited Settings
David B. Meya et al.
CLINICAL INFECTIOUS DISEASES (2010)
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
Benjamin J. Park et al.
AIDS (2009)
Screening for Cryptococcal Antigenemia in Patients Accessing an Antiretroviral Treatment Program in South Africa
Joseph N. Jarvis et al.
CLINICAL INFECTIOUS DISEASES (2009)
Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal:: a 7-year cohort study
JF Etard et al.
AIDS (2006)
Primary and opportunistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus
Claudine Bekondi et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2006)
Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme
SD Lawn et al.
AIDS (2005)
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults
N French et al.
AIDS (2002)
Share Paper
